INVITATION TO PARTICIPATE
CONTROLLING DIABETES AND ITS MORE SEVERE COMPLICATIONS CONGRESS
8th till 12 December 2014
Varadero Convention Center, Varadero beach, Matanzas province, Cuba
In the last years the growth of diabetes prevalence to more than 371 millions of diabetic patients in the planet, has stimulated that governments, international health organizations and national health authorities target diabetes as a colossal threat focusing in set up appropriate strategies to prevent, control and diminish the menace that represent this pathology and its complications. Every year the celebration in almost all continents and territories of more than 70 International Congress targeting Diabetes, describes the global interest in controlling diabetes and minimizing its impact.
The Organizing Committee of the 3rd Edition of the International Congress about “The INTEGRAL CARE OF DIABETIC FOOT ULCER PATIENTS” (http://hptcongress.cigb.edu.cu/ ) is pleased to inform you that our Congress have expanded its scope and from now their bi annual editions will be called: CONTROLLING DIABETES AND ITS MORE SEVERE COMPLICATIONS
The meeting will include key lectures offered by outstanding world speakers from the field of diabetes mellitus, basic research in wound healing, world state of the art in diabetic foot ulcer treatments, and design of health programs for improving quality of life of diabetic patients.
All these subjects will be discussed through the parallel celebration of four symposiums during December 10 to 12, 2014;
- Symposium 1: it will be dedicated to Diabetes control from an endocrinal perspective, including prevention, patient metabolic control and procedures to diminish the risk of diabetic complications.
- Symposium 2: It will be dedicated to the molecular biology of wound healing, the molecular mechanisms of healing factors and design and results of clinical trials addressed to evaluate wound healing therapies.
- Symposium 3: It will be dedicated to the state of the art of diabetic foot ulcer treatments mainly in complex ulcers, including the use of human recombinant epidermal growth factor (hrEGF) applied by infiltration in diabetic ulcers (Heberprot-P).
- Symposium 4: It will be dedicated to discuss about strategies for implement Programs conducted by Health Ministries towards the Integral Care of Diabetic Patients at the Primary, Secondary and Tertiary Attention Health Levels and its pharmaco economics and its pharmaco-surveillance.
Two days before the Congress, and with optional character, December 8th and 9th 2014, an International Workshop Course: “Practical Application of Heberprot-P in Diabetic Foot Ulcer Patients”, will be organized for medical doctors who wish to familiarize with this treatment. Heberprot-P is a novel therapy having as Active Pharmaceutical Ingredient (API) the human recombinant Epidermal Growth Factor (hrEGF)) which is applied through direct infiltration at the ulcer area, accomplishing in most of the cases the formation of healthy granulation tissues able to promote total healing in a shorter period of time.
Hoping to count with your contributions, I kindly invite you to participate in the 3rd Edition of the International Congress “CONTROLLING DIABETES AND ITS MORE SEVERE COMPLICATIONS submitting to our congress website the title and summary of your work either in English or in Spanish (preferably in English) before June 30th, 2014.
FOR FUTHER INFORMATION PLEASE CONTACT